Ocugen Inc (NASDAQ: OCGN) shares are trading higher by 3.35% to $1.88 Wednesday morning after the company announced it entered into an exclusive license agreement with Washington University in St.
Ocugen's intranasal candidate is one of the world's most advanced intranasal COVID-19 vaccines
Intranasal vaccine is designed to curb virus transmission and confer protective immunity
MALVERN, Pa., Sept. 28,
Companies Reporting Before The Bell
• Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.